You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Thermo Fisher's test is now authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens.
The NGS-based test is intended for use by lab personnel trained to use Illumina's MiSeq and NextSeq systems.
News items for the week of Sept. 28, 2020
Planned and ongoing studies will use standardized plasma protein profiling workflows to discover biomarkers for a range of conditions.
An international team of researchers put nine immune cell sequencing methods head to head, including RNA-based and DNA-based ones, using the same T-cell sample.
Thermo Fisher said the assay is the first and, so far, only FDA-approved test of its kind for a targeted treatment for RET fusion-positive NSCLC.
Healthcare providers need multiplexed tests that can differentiate the flu from the coronavirus so they can treat patients quickly and appropriately.
The international competition's goal is to spark innovation and accelerate safe returns to work, school, and other public activities.
The method uses DIA mass spec runs to adjust for drifts in LC retention times, allowing researchers to schedule more highly multiplexed experiments.
New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.
The US National Institutes of Health has a new initiative to address structural racism in biomedical research.
According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.
In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.